(Total Views: 462)
Posted On: 09/25/2024 5:34:56 PM
Post# of 154246
Re: Buddyboy20 #146626
Quote:
It looks like there is a better PD-1 inhibitor than Merk's Keytruda. Merk might be better motivated to find a better cancer treatment, than their current checkpoint inhibitor.
It's understandable that ivonescimab beats Keytruda. It's not just a PD-1 inhibitor like Keytruda but a PD-1/VEGF inhibitor. That's two of the dozens of factors that leronlimab addresses.
(13)
(0)
